I think those that lurk on this forum and have read a lot of the...

I think those that lurk on this forum and have read a lot of the great knowledge floating around are quietly confident about the upcoming phase 2 OSA results. They would be aware of why this is significant (huge market, standard of care has big room for improvement), and would be aware of the context that signals that we should be optimistic (constituent drugs shown efficacy in humans against same endpoints as the trials, extension trial happening, preliminary results supporting patent application, and more).

Lots of impatient holders out there.